Kharade, Sujay V <br/><br/>
The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics.  [electronic resource] 

 -  Future medicinal chemistry  05 2016 
 - 789-802 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1756-8927 
<br/><br/><label>Standard No.: </label>10.4155/fmc-2016-0005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine Nucleotides--pharmacology<br/>Animals<br/>Cardiomegaly--drug therapy<br/>Channelopathies--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Humans<br/>Hyperinsulinism--congenital<br/>Hypertrichosis--drug therapy<br/>Hypoglycemic Agents--pharmacology<br/>Ion Channel Gating<br/>KATP Channels--antagonists & inhibitors<br/>Osteochondrodysplasias--drug therapy<br/>Protein Transport